{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000343.3:c.90G>A",
          "cDNA Change": {
            "transcript": "NM_000343.3",
            "ref": "G",
            "alt": "A",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in alpha-synuclein (SNCA)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004984"
  },
  "Experiment Method": [
    {
      "Assay Method": "Inducible cell model with autophagy/proteasome inhibition",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "PC12/TetOn cells",
        "Description": "Inducible expression of wild-type and A30P SNCA in PC12/TetOn cells with 3-MA (autophagy inhibitor) or MG132 (proteasome inhibitor)."
      },
      "Readout type": "Qualitative and quantitative",
      "Readout description": [
        {
          "Variant": "NM_000343.3:c.90G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Aggregation observed under autophagy/proteasome inhibition",
          "Result Description": "A30P variant aggregates when autophagy (3-MA) or proteasome (MG132) is inhibited, while wild-type SNCA does not."
        },
        {
          "Variant": "Wild-type",
          "Conclusion": "Normal",
          "Molecular Effect": "No aggregation observed",
          "Result Description": "Wild-type SNCA does not aggregate under autophagy/proteasome inhibition."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Replication details not specified in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Replication details not specified in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Controls not explicitly described in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Controls not explicitly described in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No aggregation observed in wild-type SNCA under inhibitor conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation detected in A30P variant under inhibitor conditions.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Rationale": "Cell-based models and inhibitor-induced aggregation assays are standard in Parkinson's disease research."
      }
    }
  ]
}